Remy Durand

Chief Business Officer, Alpine Immune Sciences.

Companies

Alpine Immune SciencesChief Business Officer Apr 27, 2023 to May 20, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

May 20, 2024Returned to company 31,200 shares of CIK 1626199²
May 20, 2024Returned to company 102,192 shares of CIK 1626199²
May 8, 2024Exercised options 10,000 shares at $4.76 of CIK 1626199³
May 8, 2024Exercised options 38,078 shares at $3.23 of CIK 1626199³
May 8, 2024Exercised options 12,365 shares at $4.09 of CIK 1626199³
May 8, 2024Exercised options 25,000 shares at $6.51 of CIK 1626199³
May 8, 2024Exercised options 9,845 shares at $13.20 of CIK 1626199³
Jan 4, 2024Granted 31,200 shares of CIK 1626199⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlpine Immune Sciences, Chief Business Officer
2
SEC EDGARForm 4 filed May 20, 2024
3
SEC EDGARForm 4 filed May 10, 2024
4
SEC EDGARForm 4 filed Jan 5, 2024